Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-159,894
Closed -$686K 993
2019
Q1
$686K Buy
159,894
+70,016
+78% +$322K 0.01% 594
2018
Q4
$352K Sell
89,878
-6,485
-7% -$27.7K 0.01% 753
2018
Q3
$440K Buy
+96,363
New +$459K 0.01% 755
2017
Q3
Sell
-3,928
Closed -$21K 1076
2017
Q2
$21K Sell
3,928
-28,265
-88% -$161K ﹤0.01% 1810
2017
Q1
$185K Buy
32,193
+7,206
+29% +$39.5K ﹤0.01% 972
2016
Q4
$122K Buy
24,987
+2,895
+13% +$15.6K ﹤0.01% 1210
2016
Q3
$134K Buy
+22,092
New +$132K ﹤0.01% 1118
2014
Q2
Sell
-625
Closed -$4K 2085
2014
Q1
$4K Hold
625
﹤0.01% 1950
2013
Q4
$4K Buy
+625
New +$4.57K ﹤0.01% 1881

Other funds holding ABEV

D.A. Davidson & Co's ABEV Position: Q2 2019 in Review

D.A. Davidson & Co sold out of Ambev (ABEV) in Q2 2019, closing a stake of 159,894 shares — an estimated $686K sold.

D.A. Davidson & Co first reported a position in ABEV in Q4 2013 and held it in 9 quarters. The position peaked at $686K in Q1 2019. 309 funds tracked by Wall St. Rank hold ABEV as of Q2 2019.

  • D.A. Davidson & Co reported no remaining Ambev position as of Q2 2019 after selling out during the quarter.
  • D.A. Davidson & Co sold 159,894 Ambev shares in Q2 2019, an estimated $686K.
  • D.A. Davidson & Co first reported a position in Ambev in Q4 2013 and held it in 9 quarters.
  • D.A. Davidson & Co's Ambev position peaked at $686K in Q1 2019.
  • 309 funds tracked by Wall St. Rank held Ambev as of Q2 2019.

Based on D.A. Davidson & Co's 13F filing for Q2 2019, filed 13 Aug 2019.